Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
New hydrazide derivatives of N-amino-11-azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple-negative breast cancer.
Arch Pharm (Weinheim). 2024 Nov;357(11):e2400466. doi: 10.1002/ardp.202400466. Epub 2024 Sep 13.
Arch Pharm (Weinheim). 2024.
PMID: 39267485
Epidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells.
Kar T, Dugam P, Shivhare S, Shetty SR, Choudhury S, Sen D, Deb B, Majumdar S, Debnath S, Das A.
Kar T, et al. Among authors: dugam p.
Cancer Rep (Hoboken). 2024 Mar;7(3):e2049. doi: 10.1002/cnr2.2049.
Cancer Rep (Hoboken). 2024.
PMID: 38522013
Free PMC article.
Item in Clipboard
Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies.
Mekala S, Dugam P, Das A.
Mekala S, et al. Among authors: dugam p.
J Cell Commun Signal. 2023 Sep;17(3):549-561. doi: 10.1007/s12079-023-00750-1. Epub 2023 Apr 27.
J Cell Commun Signal. 2023.
PMID: 37103689
Free PMC article.
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.